Frédéric Desmoulins

Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders

The interplay between cytokines, inflammation, and antioxidants: mechanistic insights and therapeutic potentials of various antioxidants and anti-cytokine compounds

Low numbers of blood and salivary natural killer cells are associated with a better response to belimumab in primary Sjögren’s syndrome: results of the BELISS study

Efficacy and safety of belimumab in primary Sjögren’s syndrome: results of the BELISS open-label phase II study